Crossmark

Development of Eudragit-Based Nanofiber Formulations for Colon-Targeted Delivery of Hydrocortisone in Inflammatory Bowel Disease

Crossref DOI link: https://doi.org/10.1007/s12247-026-10771-z

Published Online: 2026-06-06

Published Print: 2026-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tuğcu-Demiröz, Fatmanur https://orcid.org/0000-0002-9468-3329
Saar, Sinem https://orcid.org/0000-0001-6892-5497
Yıldız, Ayşegül https://orcid.org/0000-0002-3435-0530
Yıldırım, Emine https://orcid.org/0009-0007-4987-1471
Uyar, Recep https://orcid.org/0000-0002-7788-6685
Turgut-Birer, Yağmur https://orcid.org/0000-0002-8918-3135
Yurdakok-Dikmen, Begüm https://orcid.org/0000-0002-0385-3602
Acartürk, Füsun https://orcid.org/0000-0001-9515-750X
Funding

Funding for this research was provided by:

Gazi University
License Information

Text and Data Mining valid from 2026-06-06

Version of Record valid from 2026-06-06
More Information

Article History

Received: 4 December 2025

Accepted: 12 May 2026

First Online: 6 June 2026

Declarations

:

: The authors declare no competing interests.